[["this study", "investigated", "the response of TSH secretion to T3 and Triac"], ["the responses", "were compared with", "those in patients with TSH-secreting pituitary adenoma and normal subjects"], ["short-term administration of 75 microg of T3 daily for 7 days", "suppressed", "serum TSH concentrations almost completely in normal subjects"], ["75 microg of T3", "suppressed", "TSH only partially in patients with resistance to thyroid hormone and TSH-secreting pituitary adenoma"], ["a single-dose administration of 75 microg of T3", "gave", "similar results in regard to TSH suppressibility in three subject groups"], ["a single-dose administration of 1.4 mg of Triac", "remarkably suppressed", "serum TSH concentrations after 2 hours in normal subjects"], ["serum TSH concentrations", "were suppressed", "by 34 +/- 11% from the basal value in normal subjects after Triac"], ["serum TSH concentrations", "were suppressed", "by 31 +/- 9% in patients with resistance to thyroid hormone after Triac"], ["TSH suppression", "continued", "for 4 hours after Triac administration"], ["TSH suppression", "persisted", "in normal subjects after 24 hours"], ["TSH suppression", "was relieved", "in patients with resistance to thyroid hormone after 24 hours"], ["molar ratios of alpha-subunit to TSH in serum", "were decreased", "in patients with TSH-secreting pituitary adenoma"], ["molar ratios of alpha-subunit to TSH in serum", "were increased", "in patients with resistance to thyroid hormone"], ["Triac therapy for patients with resistance to thyroid hormone", "suppressed", "pituitary-TSH secretion during the early phase of drug ingestion"], ["Triac", "should be given", "several times within a day to obtain continuous TSH-suppressive effects"]]